Technology Transfer Enterprise Selection - Indoline derivatives for treatment and/or prevention of tumor or cell proliferatinve and fibrosid diseases
File size: 69kb
1、Technology：Indoline derivatives for treatment and/or prevention of tumor or cell proliferatinve and fibrosid diseases
2、Provider：Prof. Chia-Ron Yang School of Pharmacy, College of Medicine, NTU
3、Enterprise Eligibility：
(1). Industry Category: Biotechnology and medicine
(2). Required Technical Know-how: New drug development
(3). Required Machinery and Equipment：None
(4). Required Research or Technical Staff：New drug development
(5). Other Requirements：None
4.How to apply? Please go to the Center of Industry-Academia Collaboration of the Office of Research and Development to inquire about relevant information.
5.Announcement period：From the announcement date to 2024/2/7, late applications will not be accepted. Those who send materials by mail shall use the postmark as evidence.
6、Contact window:
Intellectual Property & Licensing Manager：Winston Pan
TEL：+886-2-3366-6651
Email： lutepan@ntu.edu.tw
7、Please refer to the attachment for the technical disclosure information of this case, and download the documents required for the application from the link (https://ord.ntu.edu.tw/w/ordntu/Alumnus_20072014421396936)
